We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Healgen

Healgen Scientific develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. The Healgen... read more Featured Products: More products

Download Mobile App





Healgen Scientific Exhibits Broad Diagnostic Portfolio at ADLM 2026

By LabMedica International staff writers
Posted on 28 Jul 2026

At ADLM 2026, Healgen Scientific is showcasing a broad diagnostic portfolio covering infectious diseases, toxicology, women’s health, urinalysis, fluorescent immunoassays, point-of-care testing, biochemistry, and animal health. More...

The company is presenting these solutions during the Clinical Lab Expo, held July 26–30 at the Anaheim Convention Center in California.

A key focus of the company’s exhibit is infectious disease testing. Healgen is showcasing rapid tests for respiratory infections, sexually transmitted infections, blood-borne diseases, and tropical and vector-borne conditions, including malaria, dengue, and Zika. The portfolio is designed to support testing across laboratories, clinics, and point-of-care environments.

In toxicology, Healgen is presenting urine and oral-fluid drug tests alongside harm-reduction products. The company is also highlighting the HealSnap mobile application, which supports its toxicology testing solutions and is intended to extend digital capabilities around rapid test workflows.

The company’s women’s health portfolio includes tests for pregnancy, ovulation, menopause, urinary tract infections, and vaginal pH. Healgen is additionally featuring multiparameter urinalysis strips covering clinical chemistry indicators such as glucose, ketones, protein, nitrite, and microalbumin.

Healgen is also showcasing benchtop and handheld fluorescent immunoassay platforms designed for testing across multiple clinical areas. Available applications include anemia, cardiovascular disease, diabetes, fertility, kidney injury, respiratory disease, thyroid disorders, and toxicology.

For laboratories seeking instrument-based and automated workflows, the exhibit includes the GeneStream real-time PCR system, the CLIA-go Pro platform, chemiluminescence technologies, automatic biochemistry analyzers, and dry chemistry systems. These solutions are intended to address testing needs ranging from decentralized clinical settings to professional and high-throughput laboratories.

The company is additionally presenting animal health solutions for companion and food animals. The portfolio includes rapid tests, molecular diagnostic technologies, and biochemistry systems designed to support veterinary testing across different care and production environments.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Pipette Calibration System
Artel PCS®
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.